However, in SAMP1/YitFc spontaneous chronic murine colitis model, IL-33 administration worsens the chronic intestinal inflammation by enhancing eosinophil infiltration and increasing pathogenic Th2 response [83]; these effects can be reversed by blockade of IL-33 signaling or depletion of eosinophils and required gut microbiomes [83, 84]. The gene discussed is IL33; the disease is inflammatory response.